Founders Financial Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Founders Financial Securities’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,379	Closed	-$960K	–	259
2021 Q2	$960K	Sell	10,379 -1,603	-13%	-$136K	0.19%	108
2021 Q1	$1.06M	Buy	11,982 +221	+2%	+$21.9K	0.25%	84
2020 Q4	$1.1M	Buy	11,761 +1,854	+19%	+$148K	0.26%	68
2020 Q3	$631K	Buy	9,907 +5,559	+128%	+$326K	0.2%	75
2020 Q2	$227K	Buy	+4,348	New	+$186K	0.07%	149
2019 Q4	–	Sell	-8,183	Closed	-$242K	–	122
2019 Q3	$242K	Sell	8,183 -4,201	-34%	-$137K	0.08%	119
2019 Q2	$427K	Buy	12,384 +3,232	+35%	+$104K	0.14%	88
2019 Q1	$301K	Buy	+9,152	New	+$270K	0.1%	99

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Founders Financial Securities's ARKG Position: Q3 2021 in Review

Founders Financial Securities sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 10,379 shares — an estimated $960K sold.

Founders Financial Securities first reported a position in ARKG in Q1 2019 and held it in 8 quarters. The position peaked at $1.1M in Q4 2020. 468 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

Founders Financial Securities reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
Founders Financial Securities sold 10,379 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $960K.
Founders Financial Securities first reported a position in ARK Genomic Revolution ETF in Q1 2019 and held it in 8 quarters.
Founders Financial Securities's ARK Genomic Revolution ETF position peaked at $1.1M in Q4 2020.
468 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Founders Financial Securities's 13F filing for Q3 2021, filed 15 Nov 2021.